Humoral vaccine response and COVID-19 hospitalizations in vaccinated multiple sclerosis patients treated with rituximab

被引：0
|
作者：
Torgauten, H. [1 ]
Onyangp, T. [2 ]
Hallin, E. [3 ]
Serkland, T. [3 ]
Skrede, S. [4 ]
Cox, R. [4 ]
Langeland, N. [4 ]
Myhr, K. [1 ]
Torkildsen, O. [1 ]
机构：
[1] Univ Bergen, Dept Clin Med, Bergen, Norway
[2] Univ Bergen, Influenza Ctr, Bergen, Norway
[3] Haukeland Hosp, Dept Med Biochem & Pharmacol, Bergen, Norway
[4] Univ Bergen, Dept Clin Sci, Fac Med, Bergen, Norway
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-657
引用
收藏
页码：736 / 736
页数：1
相关论文
共 50 条
  • [31] COVID-19 in cladribine-treated patients with multiple sclerosis
    Oreja-Guevara, C.
    Meca-Lallana, V.
    Brieva, L.
    Fernandez-Diaz, E.
    Garcia-Dominguez, J. M.
    Garcia-Estevez, D.
    Llorens, G.
    Moreno-Torres, I.
    Valenzuela, F. J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 59 - 60
  • [32] Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab
    Adamec, Ivan
    Rogic, Dunja
    Penz, Monika-Gabriele
    Braun, Carola
    Habek, Mario
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2022, 362
  • [33] COVID-19 in teriflunomide-treated patients with multiple sclerosis
    Amir Hadi Maghzi
    Maria K. Houtchens
    Paolo Preziosa
    Carolina Ionete
    Biljana D. Beretich
    James M. Stankiewicz
    Shahamat Tauhid
    Ann Cabot
    Idanis Berriosmorales
    Tamara H. W. Schwartz
    Jacob A. Sloane
    Mark S. Freedman
    Massimo Filippi
    Howard L. Weiner
    Rohit Bakshi
    [J]. Journal of Neurology, 2020, 267 : 2790 - 2796
  • [34] Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: A study of the Swedish multiple sclerosis registry
    Spelman, Tim
    Forsberg, Lars
    McKay, Kyla
    Glaser, Anna
    Hillert, Jan
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (07) : 1051 - 1059
  • [35] COVID-19 in teriflunomide-treated patients with multiple sclerosis
    Maghzi, Amir Hadi
    Houtchens, Maria K.
    Preziosa, Paolo
    Ionete, Carolina
    Beretich, Biljana D.
    Stankiewicz, James M.
    Tauhid, Shahamat
    Cabot, Ann
    Berriosmorales, Idanis
    Schwartz, Tamara H. W.
    Sloane, Jacob A.
    Freedman, Mark S.
    Filippi, Massimo
    Weiner, Howard L.
    Bakshi, Rohit
    [J]. JOURNAL OF NEUROLOGY, 2020, 267 (10) : 2790 - 2796
  • [36] COVID-19 in multiple sclerosis patients treated with dimethyl fumarate
    Capone, Fioravante
    Ferraro, Elisabetta
    Motolese, Francesco
    Di Lazzaro, Vincenzo
    [J]. JOURNAL OF NEUROLOGY, 2021, 268 (09) : 3132 - 3134
  • [37] COVID-19 in multiple sclerosis patients treated with dimethyl fumarate
    Fioravante Capone
    Elisabetta Ferraro
    Francesco Motolese
    Vincenzo Di Lazzaro
    [J]. Journal of Neurology, 2021, 268 : 3132 - 3134
  • [38] Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod
    Capuano, Rocco
    Altieri, Manuela
    Conte, Miriana
    Bisecco, Alvino
    D'Ambrosio, Alessandro
    Donnarumma, Giovanna
    Grimaldi, Elena
    Coppola, Nicola
    Medici, Nicola
    Galdiero, Massimiliano
    Tedeschi, Gioacchino
    Gallo, Antonio
    [J]. JOURNAL OF NEUROLOGY, 2022, 269 (12) : 6185 - 6192
  • [39] Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod
    Rocco Capuano
    Manuela Altieri
    Miriana Conte
    Alvino Bisecco
    Alessandro d’Ambrosio
    Giovanna Donnarumma
    Elena Grimaldi
    Nicola Coppola
    Nicola Medici
    Massimiliano Galdiero
    Gioacchino Tedeschi
    Antonio Gallo
    [J]. Journal of Neurology, 2022, 269 : 6185 - 6192
  • [40] PROLONGED COVID-19 IN PATIENTS TREATED WITH RITUXIMAB
    Weber, Andrew
    Aviv, Rachel
    Singas, Effie
    [J]. CHEST, 2021, 160 (04) : 291A - 291A
12345